Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 15, 2015 01:20 ET | Source: Vifor Pharma Ltd.

Swissmedic approva Akynzeo® (netupitant/palonosetron) per l'uso in Svizzera nella prevenzione di nausea e vomito indotti da chemioterapia (CINV)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} - Prima combinazione fissa che agisce su due...
December 15, 2015 01:20 ET | Source: Vifor Pharma Ltd.

Swissmedic lässt Akynzeo® (Netupitant/Palonosetron) zur Prävention von Chemotherapie-induzierter Übelkeit und Erbrechen (CINV) für die Schweiz zu

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} - Erste Fixkombination, die in zwei...
October 22, 2015 01:18 ET | Source: Vifor Pharma Ltd.

Soho Flordis International sigla un accordo per acquistare Potters e il portafoglio del marchio Equazen(TM) da Vifor Pharma

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Soho Flordis International (SFI)...
October 22, 2015 01:18 ET | Source: Vifor Pharma Ltd.

Soho Flordis International a signé un accord pour l'acquisition de Potters et le portefeuille de la marque Equazen(TM) à Vifor Pharma

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Soho Flordis International (SFI), par...
October 22, 2015 01:18 ET | Source: Vifor Pharma Ltd.

Soho Flordis International signs an agreement for the acquisition of Potters and the Equazen(TM) brand portfolio from Vifor Pharma

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Soho Flordis International (SFI),...
October 22, 2015 01:18 ET | Source: Vifor Pharma Ltd.

Soho Flordis International unterzeichnet eine Vereinbarung zur Übernahme von Potters und des Equazen(TM) Markenportfolios von Vifor Pharma

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Soho Flordis International (SFI) wird...
August 31, 2015 06:07 ET | Source: Vifor Pharma Ltd.

Meta-analysis links Ferinject(R) treatment of iron deficiency to reduced rate for cardiovascular hospitalisations and deaths in systolic heart failure patients

GLATTBRUGG, Switzerland, Aug. 31, 2015 (GLOBE NEWSWIRE) -- This meta-analysis, presented at ESC Congress 2015, was performed using the four available completed double-blind trials conducted in...
August 31, 2015 06:01 ET | Source: Vifor Pharma Ltd.

Méta-analyse établit lien entre le traitement de la carence en fer par Ferinject® et la réduction du taux d'hospitalisation et de décès cardiovasculaires chez les patients souffrant d'ICC systolique

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Cette méta-analyse, qui sera présentée...
August 31, 2015 06:01 ET | Source: Vifor Pharma Ltd.

Meta-Analyse belegt, dass Behandlung von Eisenmangel mit Ferinject mit einer reduzierten kardiovaskulär bedingten Hospitalisierungs- & Mortalitätsrate bei Patienten mit systolischer CHF assoziiert ist

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Die am ESC-Kongress 2015 vorgestellte...
August 31, 2015 06:01 ET | Source: Vifor Pharma Ltd.

Meta-analysis links Ferinject® treatment of iron deficiency to reduced rate for cardiovascular hospitalisations and deaths in systolic heart failure patients

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px;...